The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: A double-blind randomized placebo-controlled trial
- 1 February 2010
- journal article
- research article
- Published by Elsevier in Schizophrenia Research
- Vol. 116 (2-3) , 101-106
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- MirtazapineCNS Drugs, 2009
- Mirtazapine add‐on therapy in the treatment of schizophrenia with atypical antipsychotics: a double‐blind, randomised, placebo‐controlled clinical trialHuman Psychopharmacology: Clinical and Experimental, 2009
- Added ondansetron for stable schizophrenia: A double blind, placebo controlled trialSchizophrenia Research, 2009
- Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: A double-blind randomized placebo-controlled studyProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2008
- Emerging drugs for schizophreniaExpert Opinion on Emerging Drugs, 2008
- Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or Cul‐de‐sac?Acta Psychiatrica Scandinavica, 2007
- Treatment of Schizophrenia Negative Symptoms: Future ProspectsSchizophrenia Bulletin, 2006
- Pharmacotherapy of Schizophrenia: The Past, Present and FutureCurrent Drug Therapy, 2006
- Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled studyInternational Clinical Psychopharmacology, 2001
- Cyproheptadine in treatment of chronic schizophrenia:a double‐blind, placebo‐controlled studyJournal of Clinical Pharmacy and Therapeutics, 1999